Internal Medicine, Infectious Disease · Gainesville, FL
NPI
1699733402
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 NW 43rd St, Suite#1
Gainesville, FL, 32607
Phone (352) 378-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$158K
244,238 services
Medicare patients, 2024
294
Average age 74
Drug cost, 2024
$1.0M
919 prescriptions
Company payments, 2025
$265
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marie A Kima was code J0878 (injection, daptomycin, 1 mg), 232,794 times for 20 patients. In total Marie A Kima billed 244,238 services in 45 codes, and Medicare paid $158K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 232,794 | 20 | $0.04 | $8,940 |
| J0692 Injection, cefepime hydrochloride, 500 mg | Office | 2,851 | 25 | $1.00 | $2,843 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,274 | 16 | $0.37 | $471 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 826 | 47 | $0.51 | $419 |
| 96365 Intravenous Infusion, Hydration | Office | 548 | 44 | $47.20 | $26K |
| 99233 Hospital E&M - Subsequent | Facility | 395 | 138 | $92.92 | $37K |
| 99232 Hospital E&M - Subsequent | Facility | 265 | 100 | $61.63 | $16K |
| 99213 Office E&M - Established | Office | 188 | 116 | $67.84 | $13K |
| 99223 Hospital E&M - Initial | Facility | 169 | 144 | $133.26 | $23K |
| 96374 Injection Administration | Office | 152 | 14 | $27.71 | $4,211 |
| 96367 Intravenous Infusion, Hydration | Office | 110 | 16 | $21.37 | $2,351 |
| 96521 Chemotherapy | Office | 99 | 11 | $93.17 | $9,224 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 95 | 21 | $1.01 | $96.11 |
| J1644 Injection, heparin sodium, per 1000 units | Office | 60 | 11 | $0.18 | $10.73 |
| 36415 Venipuncture Blood Collection | Office | 54 | 28 | $8.65 | $467 |
By year: 2022 $237K for 202,346 services; 2023 $214K for 308,881 services; 2024 $158K for 244,238 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 54 | 28 | $8.65 | $467 |
Medicare prescription drug claims, 2024
In 2024, the drug Marie A Kima prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 92 prescriptions and refills. In total Marie A Kima wrote 919 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 92 | 102 | 13 | $402K |
| Minocycline Hcl Generic | 79 | 101 | 43 | $2,220 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 52 | 82 | Under 11 | $44K |
| Doxycycline Hyclate Generic | 42 | 74 | 20 | $1,012 |
| Cephalexin Generic | 41 | 71 | 12 | $606 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 35 | 35 | Under 11 | $147K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 31 | 39 | Under 11 | $304 |
| Methenamine Hippurate Generic | 27 | 35 | Under 11 | $1,142 |
| Fluconazole Generic | 26 | 36 | 19 | $524 |
| Ciprofloxacin Hcl Generic | 26 | 30 | 13 | $468 |
| Ceftriaxone Ceftriaxone Sodium | 25 | 25 | Under 11 | $919 |
| Atazanavir Sulfate Generic | 22 | 35 | Under 11 | $3,852 |
| Ritonavir Generic | 22 | 26 | Under 11 | $1,477 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 19 | 43 | Under 11 | $3,177 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 18 | 36 | Under 11 | $387 |
Brand drugs: 268 claims; generic drugs: 651 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marie A Kima $265 ($265 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $248.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.